Variant Analyzer


GenomSys Variant Analyzer is a platform natively operating on ISO/IEC 23092 (MPEG-G ) conformant genome sequencing data that enables accurate variants identification (SNVs, indels, CNVs), annotation, and interpretation to supports professionals in the diagnostic process and selecting treatment options.

Our Variant Analyzer has been developed to address the customer’s accuracy, privacy, and usability requirements and can run both in cloud or server environments. The selective access enables to focus on required genetic targets without the need to access and analyzing the whole patient’s genomic data. The enhanced compression rate and native encryption provide an advantage for sequencing and genomic research centers.

Highlights of GenomSys Variant Analyzer

Intuitive Design and User Friendly Interface

Intuitive interface, providing professionals with a large set of easy-to-use yet powerful features including dynamic filtering options and  Varsome’s human genetic variants database.

Swiss Quality and Precision

The GenomSys Variant Analyzer is CE marked as an in-Vitro Diagnostic Medical Device according to 98/79/CE directive and hence approved for clinical-grade diagnostic purposes.

Automated and Reliable Workflow

GenomSys Variant Analyzer includes the fully integrated secondary and tertiary DNA analysis with an automated workflow for delivering reliable results in the new and more efficient MPEG-G format.


Carefully harmonized state-of-the-art bioinformatic software relying on the most updated genomic annotation provided by Varsome and nifty tools for variants filtering.

Cloud-based for ubiquitous applicability

GenomSys Variant Analyzer is designed to work in a cloud-based environment for an easy-to-use tool for geneticist running the analysis.

Downloads &
GenomSys website

About GenomSys

Founded in 2016 by a group of experienced engineers and bioinformaticians under the leadership of Claudio Alberti, our CTO, GenomSys is a Swiss company developing state-of-the-art technology and services for the efficient analysis and secure management of genomic information.

The company is a pioneer in the development of open standards for genomic data storage and processing – it led the process of standardization of ISO/IEC 23092 (MPEG-G) – and in the implementation of compliant software and tools for its effective application.

In October 2019, GenomSys secured a CHF9.3 million Series A funding to take the development of the company to the next stage.

Now GenomSys is taking the next step, enabling laboratories and end-users to take advantage of the new standard: MPEG-G native analytical pipelines for more efficient storage and focused analyses via selective access, and the ability for people to store and analyze their own genomic data in their smartphones, bringing genomics into the mobile world.

In doing so, GenomSys defines a new paradigm with a highly differentiated solution: a consistent value proposition emphasizing privacy and convenience to truly deliver personalized medicine to individuals by leveraging the uniqueness of the new digital genomic standard and the pervasiveness of mobile, directly or through business partners.

GenomSys headquarters are in the Swiss Health Valley, at the center of a hub of technology and genomic innovation around the research centers of the Ecole Polytechnique Fédérale de Lausanne and the Swiss Genome Center. The company recently opened an additional scientific center in Ticino, an emerging hub for innovation in biotechnology and digital developments in the south of Switzerland.

Our partners

Send us a message

[contact-form-7 id=”223″]